Heyholder
‹ Activism Filings

Precision Biosensor Inc. Q3 revenue KRW 7.0 billion, operating profit KRW 0.4 billion, turning profitable

Precision Biosensor Inc.· Periodic Report

AI summary · Not investment advice

Precision Bio sold KRW 7.0 billion in Q3 and earned KRW 0.4 billion from its main business, turning profitable from a loss a year earlier.

Operating profit · 3 months

KRW 412.0 million

Key facts

Revenue (3 months)
KRW 7.0 billion
Net income (3 months)
KRW -519.4 million
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 5.1 billion
Revenue (year to date)
KRW 20.3 billion
Operating profit (prior-year 3 months)
KRW -1.0 billion
Operating profit (year to date)
KRW -779.7 million
Net income (prior-year 3 months)
KRW -1.5 billion
Net income (year to date)
KRW -1.6 billion

Commentary

AI commentary · Not investment advice

What happened

Precision Bio filed its quarterly report with consolidated results for the third quarter of 2026. Sales for the latest 3 months were KRW 7.02 billion. That is 37.2% higher than the same 3 months a year earlier, which were KRW 5.12 billion.

In the company's terms

Operating profit (money earned from the core business) was KRW 412 million for the latest 3 months. A year earlier, the same period showed an operating loss of KRW 1.03 billion. So it turned to a profit.

What changes for shareholders

Net income (the final profit after taxes and other items) was a loss of KRW 519 million for the latest 3 months. A year earlier, the loss was KRW 1.52 billion.

For the year to date (January 1 to September 30), sales were KRW 20.27 billion. Operating loss was KRW 780 million. Net loss was KRW 1.55 billion.

Comments

No comments yet

Comments from shareholders will appear here.